Amgen Inc. stock rises Thursday, outperforms market - MarketWatch
| AMG Stock | 255.90 7.15 2.87% |
Slightly above 55% of Amgen's private investors are presently thinking to get in. The analysis of current outlook of investing in Amgen Inc suggests that some traders are interested regarding Amgen's prospects. Amgen's investing sentiment can be driven by a variety of factors including economic data, Amgen's earnings reports, geopolitical events, and overall market trends.
Amgen |
Amgen Inc. stock rises Thursday, outperforms market MarketWatch
Read at news.google.com
 |
Amgen Fundamental Analysis
We analyze Amgen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Amgen is rated third in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Amgen Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amgen stock to make a market-neutral strategy. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics with similar companies.
Peers
Amgen Related Equities
| AMG | Amgen | 2.87 | ||||
| GIS | General Mills | 1.44 | ||||
| BAYN | Bayer AG | 0.37 | ||||
| ZEG | AstraZeneca PLC | 0.04 | ||||
| JNJ | Johnson Johnson | 0.13 | ||||
| IDP | Biogen | 0.67 |
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.